Invitrogen Raises $325M in Sale of Convertible Notes

Jun 16, 2005

NEW YORK, June 16 (GenomeWeb News) - Invitrogen yesterday said that it has raised $325 million in a sale of convertible notes due 2025 that it announced earlier this week.

The company initially planned to offer $300 million of the 3.25-percent senior convertible notes. Purchasers had an option to purchase up to an additional $50 million to cover over-allotments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Persistent Gap

Researchers examine the gap in funding between researchers and research institutions, ScienceInsider reports

Puppies' Past

By sequencing two ancient dog genomes, researchers from the US and Germany suggest that dogs were domesticated in a single event, the Washington Post reports.

This Week in Genome Research

In Genome Research this week: population dynamics of E. coli infection, lncRNA expression changes in macaque aging, and more.

Testing for Complications

Noninvasive prenatal testing can uncover pregnancies at risk of miscarriage, New Scientist reports.

Main menu